Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxamyl SCHEMBL21327715 | 1.00 | TDP1 (0.35) | TDP1 | |
| Oxamyl SCHEMBL9276500 | 0.95 | TDP1 (0.36) | TDP1 | |
| Oxamyl SCHEMBL26950 | 0.95 | TDP1 (0.38) | TDP1 | |
| Oxamyl SCHEMBL1765917 | 0.95 | TDP1 (0.38) | TDP1 | |
| Oxamyl SCHEMBL5802654 | 0.95 | TDP1 (0.38) | TDP1 | |
| Oxamyl SCHEMBL7871702 | 0.95 | TDP1 (0.38) | TDP1 | |
| Oxamyl SCHEMBL5695469 | 0.93 | TDP1 (0.37) | TDP1 | |
| Oxamyl SCHEMBL28371792 | 0.89 | TDP1 (0.34) | TDP1 | |
| Oxamyl SCHEMBL28442757 | 0.89 | TDP1 (0.34) | TDP1 | |
| Oxamyl SCHEMBL3246496 | 0.88 | TDP1 (0.33) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105246336-B | Use of tetramic acid derivatives as nematicides | 先正达参股股份有限公司 | 2022-08-30 | — | — | CN | claimed |
| US-10246459-B2 | Use of tetramic acid derivatives as nematicides | SYNGENTA PARTICIPATIONS AG (CH) | 2019-04-02 | — | — | US | claimed |
| US-20180030052-A1 | USE OF TETRAMIC ACID DERIVATIVES AS NEMATICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2018-02-01 | — | — | US | claimed |
| EP-3003041-A1 | USE OF TETRAMIC ACID DERIVATIVES AS NEMATICIDES | Syngenta Participations AG (CH) | 2016-04-13 | — | — | EP | claimed |
| US-20160090384-A1 | USE OF TETRAMIC ACID DERIVATIVES AS NEMATICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2016-03-31 | — | — | US | claimed |
| CN-105246336-A | Use of tetramic acid derivatives as nematicides | SYNGENTA PARTICIPATIONS AG | 2016-01-13 | — | — | CN | claimed |
| WO-2014191271-A1 | USE OF TETRAMIC ACID DERIVATIVES AS NEMATICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-12-04 | — | — | WO | claimed |
| WO-2011100424-A1 | METHODS FOR REDUCING NEMATODE DAMAGE TO PLANTS | BAYER CROSCIENCE LP (US) | 2011-08-18 | — | — | WO | claimed |
| US-20110200571-A1 | Methods for Reducing Nematode Damage to Plants | BELL JOHN W | 2011-08-18 | — | — | US | claimed |
| CN-105246336-B | Use of tetramic acid derivatives as nematicides | 先正达参股股份有限公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-113811520-A | Agricultural adjuvant comprising microfibrillated cellulose | 艾姆瓦克香港有限公司 | 2021-12-17 | — | — | CN | disclosed |
| CN-113727605-A | Pesticide formulations comprising MFC as rheology modifier | 艾姆瓦克香港有限公司 | 2021-11-30 | — | — | CN | disclosed |
| EP-3003041-B1 | USE OF TETRAMIC ACID DERIVATIVES AS NEMATICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2020-03-18 | — | — | EP | disclosed |
| US-10246459-B2 | Use of tetramic acid derivatives as nematicides | SYNGENTA PARTICIPATIONS AG (CH) | 2019-04-02 | — | — | US | disclosed |
| EP-3003041-A1 | USE OF TETRAMIC ACID DERIVATIVES AS NEMATICIDES | Syngenta Participations AG (CH) | 2016-04-13 | — | — | EP | disclosed |
| US-20160090384-A1 | USE OF TETRAMIC ACID DERIVATIVES AS NEMATICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2016-03-31 | — | — | US | disclosed |
| CN-105246336-A | Use of tetramic acid derivatives as nematicides | SYNGENTA PARTICIPATIONS AG | 2016-01-13 | — | — | CN | disclosed |
| WO-2014191271-A1 | USE OF TETRAMIC ACID DERIVATIVES AS NEMATICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-12-04 | — | — | WO | disclosed |
| WO-2011100424-A1 | METHODS FOR REDUCING NEMATODE DAMAGE TO PLANTS | BAYER CROSCIENCE LP (US) | 2011-08-18 | — | — | WO | disclosed |
| US-20110200571-A1 | Methods for Reducing Nematode Damage to Plants | BELL JOHN W | 2011-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180030052-A1 | USE OF TETRAMIC ACID DERIVATIVES AS NEMATICIDES | TBCA, TUBB, TUBA1C | TDP1 1792/4885 |
| US-20160090384-A1 | USE OF TETRAMIC ACID DERIVATIVES AS NEMATICIDES | TBCA, TUBB, TUBA1C | TDP1 1792/4885 |
| US-10246459-B2 | Use of tetramic acid derivatives as nematicides | TBCA, TUBB, TUBA1C | TDP1 1792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.